Region: Global
Category: Pharmaceuticals

Global Pharmaceuticals

(23,238 reports matching your criteria)
  • Global Intravenous Iron Drugs Databank Market Report

    ... 2023 to 2031. Ferric Carboxymaltose segment is expected to be the highest contributor to this market, with $1,459.4 Million in 2022, and is anticipated to reach $2,668.4 Million by 2031, registering a CAGR of 6.98%. ... Read More

  • Global Erythropoietin Drugs Databank Market Report

    ... 2029. Cancer segment is expected to be the highest contributor to this market, with $3,381.2 Million in 2020, and is anticipated to reach $6,689.5 Million by 2029, registering a CAGR of 7.92%. Renal Diseases segment ... Read More

  • Global Food Allergy Diagnostics & Therapeutics Databank Market Report

    ... CAGR of 6.03% from 2023 to 2031. Diagnostic Products segment is expected to be the highest contributor to this market, with $2,241.8 Million in 2022, and is anticipated to reach $3,594.6 Million by 2031, registering ... Read More

  • Global Membrane Bioreactor Systems Databank Market Report

    ... 2021 to 2029. Flat Sheet segment is expected to be the highest contributor to this market, with $4,081.1 Million in 2020, and is anticipated to reach $7,726.6 Million by 2029, registering a CAGR of 7.40%. ... Read More

  • Global Stomach Cancer Treatment Databank Market Report

    ... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $2,319.0 Million in 2022, and is anticipated to reach $5,613.5 Million by 2031, registering a CAGR of 10.38%. ... Read More

  • Global Next Generation Cancer Diagnostics Databank Market Report

    ... 8.47% from 2023 to 2031. Next-Generation Sequencing segment is expected to be the highest contributor to this market, with $4,346.5 Million in 2022, and is anticipated to reach $9,095.4 Million by 2031, registering a CAGR ... Read More

  • Global Attention Deficit Hyperactivity Disorder Databank Market Report

    ... 7.15% from 2021 to 2029. Stimulants segment is expected to be the highest contributor to this market, with $350.6 Million in 2020, and is anticipated to reach $669.0 Million by 2029, registering a CAGR of ... Read More

  • Global Anti-Cancer Drug Databank Market Report

    ... 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $43,423.4 Million in 2022, and is anticipated to reach $75,119.7 Million by 2031, registering a CAGR of 6.32%. Hormonal Therapy ... Read More

  • Global Anterior Uveitis Treatment Databank Market Report

    ... 2023 to 2031. Corticosteroids segment is expected to be the highest contributor to this market, with $97.0 Million in 2022, and is anticipated to reach $125.8 Million by 2031, registering a CAGR of 2.97%. Anti-TNF ... Read More

  • Global Antacids Databank Market Report

    ... segment is expected to be the highest contributor to this market, with $4,872.4 Million in 2022, and is anticipated to reach $6,411.1 Million by 2031, registering a CAGR of 3.14%. Liquid segment is anticipated to ... Read More

  • Global Anti-Tumor Drugs Databank Market Report

    ... 2029. Chemotherapy segment is expected to be the highest contributor to this market, with $234,295.8 Million in 2020, and is anticipated to reach $496,893.9 Million by 2029, registering a CAGR of 8.76%. Hormonal Therapy segment ... Read More

  • Global Rare Hemophilia Factors Databank Market Report

    ... 2021 to 2029. Factor II segment is expected to be the highest contributor to this market, with $1,123.8 Million in 2020, and is anticipated to reach $1,801.8 Million by 2029, registering a CAGR of 5.44%. ... Read More

  • Global Squalene Databank Market Report

    ... segment is expected to be the highest contributor to this market, with $64.7 Million in 2022, and is anticipated to reach $147.9 Million by 2031, registering a CAGR of 9.69%. Plants segment is anticipated to ... Read More

  • Global Sustained Release Excipients Databank Market Report

    ... 2023 to 2031. Polymers segment is expected to be the highest contributor to this market, with $500.3 Million in 2022, and is anticipated to reach $897.6 Million by 2031, registering a CAGR of 6.76%. Alcohol ... Read More

  • Global Legal Marijuana Market Size, Manufacturers, Opportunities and Forecast to 2030

    ... on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain ... Read More

  • Global Transdermal Drug Delivery System Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

    ... deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types ... Read More

  • Global Encephalitis Vaccination Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

    ... - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be ... Read More

  • Global Zika Virus Testing Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

    ... Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most ... Read More

  • Global Dermatology Diagnostics Devices Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

    ... global Dermatology Diagnostics Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & ... Read More

  • Global Hospital Acquired Infections Therapeutic Databank Market Report

    ... 2.02% from 2023 to 2031. Antibacterial Drugs segment is expected to be the highest contributor to this market, with $9,937.3 Million in 2022, and is anticipated to reach $11,555.8 Million by 2031, registering a CAGR ... Read More

  • Global Eye Health Supplements Databank Market Report

    ... report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of ... Read More

  • Global Artificial Pancreas Device System Databank Market Report

    ... intelligence report by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding ... Read More

  • Global Beta-Carotene Industry Databank Market Report

    ... by providing detailed segmentation, growth rates, market dynamics, industry structure and developments, market situation, and trends. To determine the market size and forecast, we conducted extensive secondary research to gain a comprehensive understanding of the ... Read More

  • Global Pediatric Imaging Databank Market Report

    ... 2031. Magnetic Resonance Imaging segment is expected to be the highest contributor to this market, with $3,058.4 Million in 2022, and is anticipated to reach $5,133.5 Million by 2031, registering a CAGR of 5.97%. X-ray ... Read More

  • Global Active Pharmaceutical Ingredients CDMO Databank Market Report

    ... 11.58% from 2021 to 2029. Highly Potent Active Pharmaceutical Ingredient (HP-API) segment is expected to be the highest contributor to this market, with $53.5 Million in 2020, and is anticipated to reach $149.2 Million by ... Read More

Cookie Settings